334 filings
Page 15 of 17
8-K
zd9zkf6
17 Jun 19
Regulation FD Disclosure
5:12pm
8-K
ampe299go4 dh9c
6 Jun 19
INmune Bio to present Alzheimer’s Drug Candidate XPro1595 at The TNF Conference
4:06pm
8-K
1uour0mgshyh1db
4 Jun 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:28pm
8-K
q4kcrx2dstt
29 May 19
INmune Bio to Present at the 9th Annual LD Micro
4:49pm
8-K/A
aujbxp j7x
24 May 19
Entry into a Material Definitive Agreement
4:12pm
8-K
iihk1z4ky6u7kp
24 May 19
Entry into a Material Definitive Agreement
2:20pm
8-K
ocapshrq3v3ig50d
17 May 19
Entry into a Material Definitive Agreement
2:43pm
8-K
hk14d dt8
16 May 19
INmune Bio Reports First Quarter 2019 Financial Results and Provides Shareholder Update
6:06am
10-Q
jx6zh82g
15 May 19
Quarterly report
9:01am
8-K
iz920dfo
13 May 19
INmune Bio Closes Private Placement of Approximately $4.1 Million of Common Stock, Led by Insiders and Existing Shareholders
5:19pm
D
qg258rpk9ozhgiqx4
10 May 19
$4.7M in equity, sold $4.7M, 5 investors
12:00am
8-K
l6eo8jk9
6 May 19
Entry into a Material Definitive Agreement
5:24pm
8-K
s0omeyb7n 4b
29 Apr 19
Other Events
4:59pm
8-K
pbwyc94wkpgtbwujd4ud
19 Apr 19
INmune Bio Presenting Poster at the Neuroimmunology Drug Development Summit
5:26pm
8-K
b0hrb uwh9uy25sfy7
12 Apr 19
INmune Bio Announces Poster Presentation with New
4:38pm
8-K
r2orgouy
4 Apr 19
Regulation FD Disclosure
6:16am
10-K
uimpkz7iodt tv
29 Mar 19
Annual report
5:28pm
8-K
tiqcls
13 Mar 19
Regulation FD Disclosure
4:32pm
8-K
jn24setaox2eda7nwgvr
28 Feb 19
INmune Bio Co-Founders to Present at World
12:00am
8-K
xu3kr
13 Feb 19
INmune Bio Awarded a $1 Million Grant for the Development of XPro1595 for the treatment of Alzheimer’s Disease
12:00am